right-img

Home | Equities Research Analysts’ Updated EPS Estimates for April, 30th (HEMA, HFWA, HHC, HMSNF, HZO, I, ICAGY, IMMU, INGR, IOSP)

Equities Research Analysts’ Updated EPS Estimates for April, 30th (HEMA, HFWA, HHC, HMSNF, HZO, I, ICAGY, IMMU, INGR, IOSP)

April 30, 2019
Equities Research Analysts’ updated eps estimates for Tuesday, April 30th: HemaCare (OTCMKTS:HEMA) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “HEMACARE CORP.’s business activities include blood management programs, regional sales of blood products and blood services. Their Blood Management Programs enable hospitals to contract […]
Read more at:https://www.americanbankingnews.com/2019/04/30/equities-research-analysts-updated-eps-estimates-for-april-30th-hema-hfwa-hhc-hmsnf-hzo-i-icagy-immu-ingr-iosp.html

Site Created by finaceandbankingnewsnow.com